Derambure P

References (2)

Title : Early development of symptomatic drugs in AD: a systematic review of the use of biomarkers - Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_
Author(s) : Deguil J , Ravasi L , Lamberty Y , Auffret A , Payoux P , Leroy C , Derambure P , Bordet R
Ref : CNS Neurol Disord Drug Targets , : , 2016
Abstract : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_
ESTHER : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_
PubMedSearch : Deguil_2016_CNS.Neurol.Disord.Drug.Targets_2_
PubMedID: 27189465

Title : Effects of acetylcholinesterase inhibitors and memantine on resting-state electroencephalographic rhythms in Alzheimer's disease patients - Babiloni_2013_Clin.Neurophysiol_124_837
Author(s) : Babiloni C , Del Percio C , Bordet R , Bourriez JL , Bentivoglio M , Payoux P , Derambure P , Dix S , Infarinato F , Lizio R , Triggiani AI , Richardson JC , Rossini PM
Ref : Clin Neurophysiol , 124 :837 , 2013
Abstract : Babiloni_2013_Clin.Neurophysiol_124_837
ESTHER : Babiloni_2013_Clin.Neurophysiol_124_837
PubMedSearch : Babiloni_2013_Clin.Neurophysiol_124_837
PubMedID: 23098644